Scheme Completed

Alkermes acquisition of Avadel Pharmaceuticals

NASDAQ: AVDL

Advisers

Avadel Pharmaceuticals

Target

Financial adviser

Alkermes

Acquirer

Financial adviser
Target
Avadel Pharmaceuticals
Acquirer
Alkermes
Target based in
Ireland
Buyer based in
Ireland
Structure
Scheme of arrangement
Completed
12 Feb 2026
Sector
Pharma
Tags
Pharma, Biotech

In the league tables

Similar deals

All pharma deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.